Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: The Multi-Ethnic Study of Atherosclerosis

International Journal of Obesity

Volumn 36, Issue 6, 2012, Pages 797-804

  Steffen, B T ^a   Steffen, L M ^b   Tracy, R ^c   Siscovick, D ^d   Hanson, N Q ^a   Nettleton, J ^e   Tsai, M Y ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

epidemiology; fatty acids; inflammation; omega 3

Indexed keywords

C REACTIVE PROTEIN; DIHOMO GAMMA LINOLENIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ICOSAPENTAENOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LINOLEIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AFRICAN AMERICAN; ARTICLE; CHINESE; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; EUROPEAN AMERICAN; FAT INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; GAS CHROMATOGRAPHY; HISPANIC; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; DISEASE PROGRESSION; E-SELECTIN; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LINEAR MODELS; LINOLEIC ACID; MALE; MIDDLE AGED; OBESITY;

EID: 84862238004     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.157     Document Type: Article

References (49)

1. Shah PK. Plaque disruption and thrombosis. Potential role of inflammation and infection. Cardiol Clin 1999; 17: 271-281. (Pubitemid 29277863)
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
3. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005; 26: 1765-1773. (Pubitemid 41219850)
4. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443-477.
5. Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589-600. (Pubitemid 38716577)
6. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010; 68: 280-289.
7. Lindqvist HM, Sandberg AS, Fagerberg B, Hulthe J. Plasma phospholipid EPA and DHA in relation to atherosclerosis in 61-year-old men. Atherosclerosis 2009; 205: 574-578.
8. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E in 11 324 patients with myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-455.
9. Sun Q, Ma J, Campos H, Rexrode KM, Albert CM, Mozaffarian D et al. Blood concentrations of individual long-chain omega-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr 2008; 88: 216-223. (Pubitemid 351988702)
10. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274: 1363-1367.
11. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978; 2: 117-119. (Pubitemid 8373454)
12. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108: 155-160. (Pubitemid 36871296)
13. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91: 439-446. (Pubitemid 43236907)
14. Kalogeropoulos N, Panagiotakos DB, Pitsavos C, Chrysohoou C, Rousinou G, Toutouza M et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010; 411: 584-591.
15. Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 187-191.
16. Tian H, Lu Y, Sherwood AM, Hongqian D, Hong S. Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Invest Ophthalmol Vis Sci 2009; 50: 3613-3620.
17. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001; 20: 5-19. (Pubitemid 32244959)
18. Moussavi N, Gavino V, Receveur O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity? Obesity (Silver Spring) 2008; 16: 7-15. (Pubitemid 351271943)
19. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119: 902-907.
20. Laaksonen DE, Nyyssönen K, Niskanen L, Rissanen TH, Salonen JT. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005; 165: 193-199.
21. Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007; 9: 70-80. (Pubitemid 44921044)
22. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871-881. (Pubitemid 35215769)
23. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006; 52: 2265-2272. (Pubitemid 44925001)
24. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005; 69: 29-35. (Pubitemid 40813409)
25. Matsumoto K, Sera Y, Abe Y, Tominaga T, Horikami K, Hirao K et al. High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus. Metabolism 2002; 51: 932-934. (Pubitemid 34784824)
26. Fernández-Real JM, Broch M, Vendrell J, Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003; 26: 1362-1368. (Pubitemid 36934464)
27. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005; 82: 1178-1184. (Pubitemid 43779715)
28. Blond JP, Henchiri C, Bézard J. Delta 6 and delta 5 desaturase activities in liver from obese Zucker rats at different ages. Lipids 1989; 24: 389-395. (Pubitemid 19144928)
29. Araya J, Rodrigo R, Pettinelli P, Araya AV, Poniachik J, Videla LA. Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. Obesity (Silver Spring) 2010; 18: 1460-1463.
30. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto Jr AM et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997; 96: 4219-4225. (Pubitemid 28007447)
31. Levin G, Duffin KL, Obukowicz MG, Hummert SL, Fujiwara H, Needleman P et al. Differential metabolism of dihomo-gammalinolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem J 2002; 365: 489-496. (Pubitemid 36135320)
32. Iversen L, Fogh K, Kragballe K. Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway. Arch Dermatol Res 1992; 284: 222-226.
33. Leslie CC. Regulation of arachidonic acid availability for eicosanoid production. Biochem Cell Biol 2004; 82: 1-17. (Pubitemid 38580870)
34. Rao NL, Dunford PJ, Xue X, Jiang X, Lundeen KA, Coles F et al. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther 2007; 321: 1154-1160. (Pubitemid 46762702)
35. Stuhlmeier KM, Kao JJ, Bach FH. Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitorkappaBalpha/nuclear factor-kappaB (NF-kappaB) complex, thus suppressing the nuclear translocation of NF-kappaB. J Biol Chem 1997; 272: 24679-24683. (Pubitemid 27418686)
36. Ji Q, Zhang L, Jia H, Xu J. Pentoxifylline inhibits endotoxininduced NF-kappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci 2004; 34: 427-436. (Pubitemid 40040965)
37. Sodin-Semrl S, Taddeo B, Tseng D, Varga J, Fiore S. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 2000; 164: 2660-2666. (Pubitemid 30115498)
38. Rassias G, Kestin M, Nestel PJ. Linoleic acid lowers LDL cholesterol without a proportionate displacement of saturated fatty acid. Eur J Clin Nutr 1991; 45: 315-320.
39. Hodson L, Skeaff CM, Chisholm WA. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. Eur J Clin Nutr 2001; 55: 908-915. (Pubitemid 32927058)
40. Calder P. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003; 38: 343-352. (Pubitemid 36724290)
41. Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004; 39: 1125-1132. (Pubitemid 40129055)
42. Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A et al. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 2008; 112: 848-855.
43. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007; 178: 3912-3917. (Pubitemid 46417661)
44. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007; 447: 869-874. (Pubitemid 46920139)
45. Lo CJ, Chiu KC, Fu M, Lo R, Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res 1999; 82: 216-221. (Pubitemid 29394126)
46. Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 2004; 23: 71-78. (Pubitemid 38200837)
47. Di Nunzio M, Danesi F, Bordoni A. n-3 PUFA as regulators of cardiac gene transcription: a new link between PPAR activation and fatty acid composition. Lipids 2009; 44: 1073-1079.
48. Norling LV, Serhan CN. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J Intern Med 2010; 268: 15-24.
49. Register TC, Burdon KP, Lenchik L, Bowden DW, Hawkins GA, Nicklas BJ et al. Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. Clin Chem 2004; 50: 2185-2187. (Pubitemid 39425869)